Tempus
IPORedefining the future of precision medicine.
Public · Chicago, United States · Founded 2015 · $200.0M raised
- Headquarters
- Chicago, Illinois
- Employees
- 1001–5000
- Founded
- 2015
- Business Model
- B2B
- Website
- tempus.com
- Total Funding
- $200.0M
- Last Round
- $200.0M Series FMay 2019
- Rounds
- 1
- Type
- Public
About
Tempus AI is a health technology company that uses artificial intelligence and genomic data to enable precision medicine. Founded in 2015 in Chicago, Tempus sequences genomes and analyzes molecular and clinical data to guide treatment decisions in oncology, cardiology, radiology, and pharmacogenomics. The company went public on Nasdaq in June 2024 under ticker TEM.
Summary
Tempus is an Artificial Intelligence company based in Chicago, United States, founded in 2015. It has raised $200.0M in total across 1 round, most recently a $200.0M Series F round in May 2019.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2019
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company